Display Settings:

Format

Send to:

Choose Destination
    J Antimicrob Chemother. 1990 Aug;26(2):209-13.

    Ceftibuten--in-vitro activity against respiratory pathogens, beta-lactamase stability and mechanism of action.

    Source

    Department of Medical Microbiology, Dudley Road Hospital, Birmingham, UK.

    Abstract

    The in-vitro activity of ceftibuten against respiratory pathogenic bacteria was studied and compared with that of other oral beta-lactam agents. Ceftibuten displayed high activity against Haemophilus influenzae and Branhamella catarrhalis. There was reduced activity against Streptococcus pneumoniae (MIC90 16 mg/l). The protein binding of ceftibuten was 77% and the primary target site PBP 3. A high degree of stability to beta-lactamase hydrolysis was observed.

    PMID:
    2120175
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk